The approach to the treatment of hypertension in the elderly hypertensive should take into account the effects of the different antihypertensive drugs on the quality of life, especially in the elderly where a small reduction in health status could have an impact on their independence.
ForetteFLechowskiLRigaudASeuxMDessiFForetteB.Does the benefit of antihypertensive treatment outweigh the risk in the very elderly hypertensive patients? J Hyperts2000; 18 (suppl. 3):S9–S12.
2.
Office of Population Censuses and SurveysMortality statistics1986. Series DH2 no.13. London: HMSO; 1988.
3.
BadleyEM.An introduction to the concepts and classifications of the international classification of impairments, disabilities, and handicaps. Disability and Rehabilitation1993; 15:161–178.
4.
BulpittCJ.Controlling hypertension in the elderly. Q J Med2000; 93:203–205.
5.
BulpittCJFletcherAE.The measurement of quality of life in hypertensive patients: A practical approach. Br J Clin Pharmacol1990; 30:353–364.
6.
CalmanKC.Quality of life in cancer patients-an hypothesis. J Med Ethics1984; 10:124–127.
7.
JamesMAPotterJF.The effect of antihypertensive treatment on the quality of later years. Drug Ther1993; 1:26–39.
8.
BulpittCJFletcherAE.Quality of life evaluation of antihypertensive drugs. Pharmaco Economics1992; 2:95–102.
9.
SlevinMLPlantHLynchDDrinkwaterJGregoryWM.Who should measure quality of life, the doctor or the patient? Br J Cancer1988; 57:109–112.
10.
BulpittCJFletcherAE.Antihypertensive drugs and quality of life in the elderly. J Card Pharm1989; Suppl10:S21–S26.
11.
KittlerME.Elderly hypertensives and quality of life: Some methodological considerations. Eur Heart J1994; 14:113–121.
12.
JachuckSJBrierleyHJachuckSWillcoxPM.The effect of hypotensive drugs on quality of life. J Royal Col Gen Pract1982; 32:103–105.
13.
PrisantLMMoserM.Hypertension in the elderly. Can we improve results of therapy? Arch Intern Med2000; 160:283–289.
14.
AppelgateWBPresselSWittesJLuhrJShekelleRBCamelGHImpact of hypertensive treatment of isolated systolic hypertension on behavioral variables. Results from the Systolic Hypertension in the Elderly Trial. Arch Intern Med1994; 154:2154–2160.
15.
ApplegateWB.Quality of life during antihypertensive treatment. Lessons from the Systolic Hypertension in the Elderly Program. Am J Hypertens1998; 11:57S–61S.
16.
BulpittCJFletcherAE.Prognostic significance of blood pressure in the very old. Implications for the treatment decision. Drugs & Aging1994; 5:184–191.
17.
AndersonRTHoganPAppelLRosenRShumakerSA.Baseline correlates with quality of life among men and women in medication-controlled hypertension. The Trial of Nonpharmacologic Interventions in the Elderly (TONE). J Am Geriat Soc1997; 45:1080–1085.
18.
GrimmRHJrGranditsGACuttlerJAStewartALMcDonaldRHSvendsenKTOMHS Treatment of Mild Hypertension Study. Arch Intern Med1997; 157:638–648.
19.
HanssonLLindholmLHEkbomTDahlöfBLankeJSchersténBRandomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet1999; 354:1751–1756.
20.
KendallMJ.Conventional versus newer antihypertensive therapies—a draw. Lancet2000; 354:1744–1745.
21.
WeirMRFlackJMApplegateWB.Tolerability, safety, and quality of life and hypertensive therapy: The case for low-dose diuretics. Am J Med. 1996; 101 (suppl. 3A):83S–92.
22.
Wassertheil-SmolerSBlaufoxMDObermanADavisBRSwencionisCKnerrMOEffect of antihypertensive on sexual function and quality of life: The TAIM study. Ann Intern Med1991; 114:613–620.
23.
BulpittCJConnorMSchulteMFletcherAE.Bisoprolol and nifedipine retard in elderly hypertensive patients: Effect on quality of life. J Hum Hypertens2000; 14:205–212.
24.
FletcherAEBulpittCJChaseDMCollinsWCFurbergCDGogginTKQuality of life with three antihypertensive treatments—cilazapril, atenolol, nifedipine. Hypertension1992; 19:499–507.
25.
StaessenJAFagardRThijsLCelisHArabidzeGGBirkenhägerWHRandomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet1997; 350:757–764.
26.
ForetteFSeuxMIStaessenJAThijsLBirkenhägerWHBabarskieneMPrevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet1998; 352:1347–1351.
27.
FletcherAEBulpittCJTuomilehtoJBrowneJBosssiniAKawecka-JaszczKQuality of life of elderly patients with isolated systolic hypertension: Baseline data from the Syst-Eur trail. J Hypertens1998; 16:1117–1124.
28.
GueyffierFBulpittCJBoisselJSchronEEkbomTFagardRAntihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trial. Lancet1999; 353:793–796.
29.
HanssonLLithellHSkoogIBaroFBánkiCMBretelerMStudy on Cognition and Prognosis in the Elderly (SCOPE). Blood Press1999; 8:177–183.
